Bill
Bill > HF2009
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
91st General Assembly
Bill Summary
This bill relates to manufacturers and distributors of 340B drugs. “340B drug”, “manufacturer”, and “distributor” are defined in the bill. The bill prohibits a manufacturer or distributor from, directly or indirectly, denying, restricting, or interfering with the acquisition of a 340B drug by a covered entity, or the delivery of a 340B drug to a contract pharmacy, unless otherwise prohibited by the United States department of health and human services.
AI Summary
This bill defines "340B drug" as a covered outpatient drug sold at a reduced price by a manufacturer under a federal program (42 U.S.C. §256b) and purchased by an eligible entity, defines "distributor" as anyone other than a manufacturer involved in the wholesale distribution of prescription drugs to pharmacies, and defines "manufacturer" according to federal law. The bill's core provision prohibits manufacturers and distributors from preventing or hindering eligible entities from obtaining these discounted 340B drugs or from delivering them to pharmacies contracted by these entities, unless federal regulations specifically forbid such purchases or deliveries. This aims to ensure that organizations eligible for the 340B drug pricing program can access their medications without undue interference from drug makers or their supply chain partners.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Subcommittee recommends passage. (on 01/21/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.legis.iowa.gov/legislation/BillBook?ga=91&ba=HF2009 |
| BillText | https://www.legis.iowa.gov/docs/publications/LGI/91/attachments/HF2009.html |
Loading...